Abstract
Muscular dystrophy, a genetically induced and highly lethal disease, necessitates urgent curative solutions. Many therapeutic drugs for this condition incorporate heterocyclic compounds. This study presents the synthesis, spectral analysis (FT-IR, 1HNMR , 13CNMR , HSQC, Mass), X-ray crystallography, molecular structure examination, electronic properties, and in-silico investigations of 3-((4-nitrophenyl)(p-tolylamino)methyl)-1H-indole-5-carbonitrile (TNIC) as a potent anti-muscular dystrophy drug. Density function theory (DFT) at the B3LYP-D3(BJ)/6-311++ (2d, 2p) level provided geometric and reactivity parameters. Computational studies explored natural bond orbitals, nonlinear optics properties, frontier molecular orbitals, quantum descriptors, and molecular electrostatic potential. Calculated wavelengths closely matched experimental values for TNIC. Molecular docking results indicated anti-muscle dystrophy effects against muscle dystrophy proteins (2VD5 and 2KKQ) with binding energies of −8.5 kcal/mol and −8.2 kcal/mol, surpassing the standard drug Deflazacort. This study highlights TNIC's significant biological activity against muscular dystrophy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.